Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Helzlsouer KJ; VDPP Steering Committee.

Am J Epidemiol. 2010 Jul 1;172(1):4-9. doi: 10.1093/aje/kwq119. Epub 2010 Jun 18.

2.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

3.

WCRF-AICR continuous update project: Systematic literature review of prospective studies on circulating 25-hydroxyvitamin D and kidney cancer risk.

Darling AL, Abar L, Norat T.

J Steroid Biochem Mol Biol. 2016 Nov;164:85-89. doi: 10.1016/j.jsbmb.2015.10.001. Epub 2015 Oct 26. Review.

PMID:
26454157
4.

The role of vitamin D in cancer prevention.

Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF.

Am J Public Health. 2006 Feb;96(2):252-61. Epub 2005 Dec 27. Review.

5.

Health outcomes of vitamin D. Part II. Role in prevention of diseases.

Wranicz J, Szostak-Węgierek D.

Rocz Panstw Zakl Hig. 2014;65(4):273-9. Review.

6.

Vitamin D: its role in cancer prevention and treatment.

Holick MF.

Prog Biophys Mol Biol. 2006 Sep;92(1):49-59. Epub 2006 Mar 10. Review.

PMID:
16566961
7.
8.

Vitamin D status and ill health: a systematic review.

Autier P, Boniol M, Pizot C, Mullie P.

Lancet Diabetes Endocrinol. 2014 Jan;2(1):76-89. doi: 10.1016/S2213-8587(13)70165-7. Epub 2013 Dec 6. Review.

9.

Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.

Chen GC, Zhang ZL, Wan Z, Wang L, Weber P, Eggersdorfer M, Qin LQ, Zhang W.

Cancer Causes Control. 2015 Dec;26(12):1719-28. doi: 10.1007/s10552-015-0665-6. Epub 2015 Sep 10. Review.

PMID:
26358829
10.

Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence.

Trowbridge R, Mittal SK, Agrawal DK.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1007-14. doi: 10.1158/1055-9965.EPI-13-0085. Epub 2013 Apr 5. Review.

11.

Vitamin D and cancer incidence in the Harvard cohorts.

Giovannucci E.

Ann Epidemiol. 2009 Feb;19(2):84-8. doi: 10.1016/j.annepidem.2007.12.002. Epub 2008 Mar 4. Review.

PMID:
18291673
12.

Epidemiology of non-steroidal anti-inflammatory drugs and cancer.

Baron JA.

Prog Exp Tumor Res. 2003;37:1-24. Review.

PMID:
12795046
13.

Optimizing vitamin D status to reduce colorectal cancer risk: an evidentiary review.

Zhou G, Stoitzfus J, Swan BA.

Clin J Oncol Nurs. 2009 Aug;13(4):E3-E17. doi: 10.1188/09.CJON.E3-E17. Review.

14.

Clinical outcomes of vitamin D deficiency and supplementation in cancer patients.

Teleni L, Baker J, Koczwara B, Kimlin MG, Walpole E, Tsai K, Isenring EA.

Nutr Rev. 2013 Sep;71(9):611-21. doi: 10.1111/nure.12047. Epub 2013 Aug 15. Review.

PMID:
24032365
15.

Vitamin D and non-Hodgkin lymphoma risk in adults: a review.

Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG.

Cancer Invest. 2009 Nov;27(9):942-51. doi: 10.3109/07357900902849632. Review.

16.

Vitamin D in the cancer patient.

Kennel KA, Drake MT.

Curr Opin Support Palliat Care. 2013 Sep;7(3):272-7. doi: 10.1097/SPC.0b013e3283640f74. Review.

18.

Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.

Birmann BM, Barnard ME, Bertrand KA, Bao Y, Crous-Bou M, Wolpin BM, De Vivo I, Tworoger SS.

Am J Public Health. 2016 Sep;106(9):1608-15. doi: 10.2105/AJPH.2016.303337. Epub 2016 Jul 26. Review.

Supplemental Content

Support Center